KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Return on Equity (2019 - 2025)

Historic Return on Equity for Castle Biosciences (CSTL) over the last 7 years, with Q3 2025 value amounting to 0.03%.

  • Castle Biosciences' Return on Equity fell 400.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year decrease of 400.0%. This contributed to the annual value of 0.04% for FY2024, which is 1900.0% up from last year.
  • Latest data reveals that Castle Biosciences reported Return on Equity of 0.03% as of Q3 2025, which was down 400.0% from 0.02% recorded in Q2 2025.
  • In the past 5 years, Castle Biosciences' Return on Equity ranged from a high of 0.04% in Q4 2024 and a low of 0.23% during Q2 2023
  • In the last 5 years, Castle Biosciences' Return on Equity had a median value of 0.08% in 2021 and averaged 0.09%.
  • Per our database at Business Quant, Castle Biosciences' Return on Equity crashed by -1200bps in 2021 and then surged by 2300bps in 2024.
  • Over the past 5 years, Castle Biosciences' Return on Equity (Quarter) stood at 0.08% in 2021, then crashed by -118bps to 0.17% in 2022, then rose by 11bps to 0.15% in 2023, then skyrocketed by 128bps to 0.04% in 2024, then tumbled by -165bps to 0.03% in 2025.
  • Its Return on Equity was 0.03% in Q3 2025, compared to 0.02% in Q2 2025 and 0.01% in Q1 2025.